Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.

Ceftazidime is a new antimicrobial agent possessing excellent in vitro activity against most members of the family Enterobacteriaceae and against Pseudomonas aeruginosa. We conducted a double-blind, prospective, multicenter trial to compare ceftazidime with moxalactam in the treatment of serious gra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Joshi, M, Anthony, W C, Tenney, J H, Drusano, G L, Caplan, E S, Standiford, H C, Henson, A, Warren, J W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1986
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC176442/
https://ncbi.nlm.nih.gov/pubmed/3530128
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak